FDA Adverse Event Injury Summary report: N

SYSMEX WORK AREA MANAGEMENT SYSTEM

MDR report key: 9841725 · Received March 17, 2020

Report

Report Number
1000515253-2020-00012
Event Type
Injury
Date Received
March 17, 2020
Date of Event
February 5, 2020
Report Date
March 17, 2020
Manufacturer
SYSMEX AMERICA INC.
Product Code
OUG
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

WHEN PROCESSING BODY FLUIDS, THE OPERATOR SELECTS THE COLOR FROM A LIST OF OPTIONS DEFINED BY THE SITE IN THE "COLOR CSF" FIELD. THESE OPTIONS INCLUDED AMBER, BROWN, CONDITION OF SPECIMEN MAKES CELL COUNT IMPOSSIBLE, COLORLESS, OTHER, PINK, RED AND XANTHOCHROMIC. THE OPERATOR ALSO SELECTED A RESULT FOR THE "XANTHOCHROMIC" FIELD. THE OPTIONS INCLUDED ABSENT, CONDITION OF SPECIMEN MAKES CELL COUNT IMPOSSIBLE OR PRESENT. IN THIS CASE, THE OPERATOR SELECTED "XANTHOCHROMIC" FOR THE "COLOR CSF" FIELD BUT SELECTED "ABSENT" FOR THE "XANTHOCHROMIC" FIELD. SYSMEX WAM IS A HEMATOLOGY INFORMATION MANAGEMENT SYSTEM THAT OFFERS A COMPREHENSIVE ANALYZER AND RESULT MANAGEMENT TOOL. SYSMEX WAM CONSOLIDATES DATA FROM MULTIPLE ANALYZERS, PERFORMS COMPLEX RULES-BASED FUNCTIONS, AIDS THE TECHNOLOGIST IN RESULTS REVIEW/DATA INTERPRETATION, AND THEN SENDS THIS INFORMATION TO THE LABORATORY INFORMATION SYSTEM (LIS). HOWEVER, IT IS THE USER'S RESPONSIBILITY TO TEST ALL WORKFLOW AND RULES PRIOR TO IMPLEMENTATION. USER ERROR CAUSED THIS EVENT. WAM PERFORMED AS DESIGNED.

Description of Event or Problem · 1

AN OPERATOR OF WORK AREA MANAGER (WAM) SYSTEM MIDDLEWARE VERSION 5.02 SELECTED "XANTHOCHROMIA" FROM THE OPTIONS FOR THE "COLOR CSF" FIELD ON A CEREBRAL SPINAL FLUID (CSF). THE OPERATOR ALSO INCORRECTLY SELECTED "ABSENT" FROM OPTIONS FOR THE "XANTHOCHROMIA" FIELD. ERRONEOUS RESULTS WERE REPORTED. A CORRECTED REPORT WAS ISSUED CHANGING THE XANTHOCHROMIA RESULT TO "PRESENT". THE OPERATOR ALLEGED A DELAY IN MULTIPLE TREATMENTS DUE TO THE ERRONEOUS RESULTS BEING RELEASED TO THE MEDICAL TEAM. THE TREATMENTS INCLUDED NIMODIPINE INITIATION, PLACEMENT OF AN EXTERNAL VENTRICULAR DRAIN, AND ADMISSION TO THE NEURO INTENSIVE CARE UNIT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
307947 SYSMEX WORK AREA MANAGEMENT SYSTEM MIDDLEWARE OUG SYSMEX AMERICA INC. WAM VERSION 5.0.2

Patients

Seq Age Sex Outcome Treatment
1 86 YR Other